ABIOMED, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a9a27b01-088f-4d3f-8f64-4af1116118e0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $1.0B | 2021-04-01 – 2022-03-31 | evidence 0000950170-22-010402 |
| FY 2020 | $847.5M | 2020-04-01 – 2021-03-31 | evidence 0001564590-21-029314 |
| FY 2019 | $840.9M | 2019-04-01 – 2020-03-31 | evidence 0001564590-20-026547 |
| FY 2018 | $769.4M | 2018-04-01 – 2019-03-31 | evidence 0001564590-19-020329 |
| FY 2017 | $593.7M | 2017-04-01 – 2018-03-31 | evidence 0001564590-19-020329 |
| FY 2016 | $445.3M | 2016-04-01 – 2017-03-31 | evidence 0001564590-19-020329 |
| FY 2015 | $329.5M | 2015-04-01 – 2016-03-31 | evidence 0001564590-18-014310 |
| FY 2014 | $229.9M | 2014-04-01 – 2015-03-31 | evidence 0001193125-15-204302 |
| FY 2013 | $183.3M | 2013-04-01 – 2014-03-31 | evidence 0001193125-14-214835 |
| FY 2012 | $157.6M | 2012-04-01 – 2013-03-31 | evidence 0001193125-13-237523 |
| FY 2011 | $125.3M | 2011-04-01 – 2012-03-31 | evidence 0001193125-12-258595 |
| FY 2010 | $99.8M | 2010-04-01 – 2011-03-31 | evidence 0001193125-12-258595 |
| FY 2009 | $84.8M | 2009-04-01 – 2010-03-31 | evidence 0001193125-12-258595 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).